Bariatric surgery: Time to move beyond clinical outcomes

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 11, 2015, Pages 829-831

  Cohen, Ricardo ^a  

^a Oswaldo Cruz German Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LAPAROSCOPY; LIFESTYLE MODIFICATION; MACROVASCULAR COMPLICATION; METABOLIC SYNDROME X; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; OBSERVATIONAL STUDY; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SWEDEN; VASCULAR DISEASE; WEIGHT REDUCTION; ECONOMICS; FEMALE; MALE;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; OBESITY;

EID: 84945438614     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00320-4     Document Type: Note

References (15)

1. Keating C, Neovius M, Sjöholm K Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol 2015, published online Sept 17. http://dx.doi.org/10.1016/S2213-8587(15)00290-9.
2. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014, 370:2002-2013. for the STAMPEDE Investigators.
3. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013, 347:f5934.
4. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012, 35:1420-1428.
5. Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013, 369:145-154. Look AHEAD Research Group.
6. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007, 357:753-761.
7. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012, 307:56-65.
8. Sjöholm K, Pajunen P, Jacobson P, et al. Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study. Diabetologia 2015, 58:1448-1453.
9. Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal-Bahl SJ Indirect costs of obesity: a review of the current literature. Obes Rev 2008, 9:489-500.
10. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2012, 23:93-102.
11. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014, 311:2297.
12. Miras AD, Chuah LL, Lascaratos G, et al. Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care 2012, 35:e81.
13. Pratt GM, McLees B, Pories WJ The ASBS Bariatric Surgery Centers of Excellence program: a blueprint for quality improvement. Surg Obes Relat Dis 2006, 2:497-503.
14. Cummings D, Cohen R Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol 2014, 2:175-181.
15. Stegenga H, Haines A, Jones K, Wilding J Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ 2014, 349:g6608. for the Guideline Development Group.